Gravar-mail: PHARMACODYNAMICALLY OPTIMIZED ERYTHROPOIETIN TREATMENT COMBINED WITH PHLEBOTOMY REDUCTION PREDICTED TO ELIMINATE BLOOD TRANSFUSIONS IN SELECTED PRETERM INFANTS